Senior COAL - Late-Phase Lung Oncology Lead

GlaxoSmithKline; Waltham (MA); On-site; USD 190,000 - 316,000; Full time

Benefits offered by this job

Health care

Retirement benefits

Paid holidays

Vacation

Paid caregiver/parental and medical-le

Job summary

GlaxoSmithKline in the United States is seeking a Clinical Operations Asset Lead (COAL) for Late Phase Lung Oncology to drive the operational strategy and end-to-end delivery of complex global programs. You will translate scientific strategy into executable plans and lead study delivery teams across multiple studies and indications.

The role requires deep therapeutic expertise in lung oncology, extensive program management experience, and the ability to partner with cross-functional teams,

Qualifications

• Bachelor's degree in life sciences, healthcare, business or a related field, or equivalent experience.
• Minimum of 10 years of pharmaceutical R&D or related industry experience.
• At least 3 years of experience as COAL (or similar role) in lung cancer indications
• 5 years + experience successfully managed global, complex programs with multiple studies
• Demonstrated experience with preparing for BLA filing (from early prep to actual filing) and BLA inspection readiness
• Deep therapeutic area expertise and solid knowledge of the lung treatment landscape and competitive environment

Responsibilities

• Own the clinical operational strategy and end-to-end delivery of the asset
• Shape the Clinical Development Plan and Integrated Evidence Plan
• Lead asset-level operational planning and scenario modelling
• Define and oversee the asset resourcing strategy
• Provide strategic leadership across Study Delivery Teams
• Drive asset-level risk management, quality and inspection readiness
• Lead operational strategies across countries, patient engagement, diversity and study execution
• Ensure robust financial, data and stakeholder governance

Skills

Analytical thinking

Clinical data interpretation

Clinical data review

Clinical development

Clinical trial designs

Clinical trials monitoring

Digital fluency

Drug regulatory affairs

Executive presence

Hematology and oncology

Learning agility

Matrix leadership

Real world evidence

Scientific presentations

Education

Bachelor's degree in life sciences or related field

Job description

GlaxoSmithKline in the United States is seeking a Clinical Operations Asset Lead (COAL) for Late Phase Lung Oncology to drive the operational strategy and end-to-end delivery of complex global programs. You will translate scientific strategy into executable plans and lead study delivery teams across multiple studies and indications.

The role requires deep therapeutic expertise in lung oncology, extensive program management experience, and the ability to partner with cross-functional teams,